Best longevity peptide stacks discussed in research
The combinations most-frequently described in published research and review articles. None of these stacks is a licensed therapeutic protocol in the UK — they are research-context combinations only.
1. GHRH analogue + GHRP (CJC-1295 + Ipamorelin)
The canonical GH-axis combination. CJC-1295 + Ipamorelin pairs a long-acting GHRH analogue with a selective ghrelin receptor agonist, producing synergistic, feedback-preserved GH release. Of all stacks discussed here this has the most-developed pharmacological rationale, although the long-term longevity-biology case for restoring youthful IGF-1 profiles in older adults is contested.
2. Mitochondrial pair: MOTS-c + SS-31
A theoretical pairing combining a mitochondrial signalling peptide (MOTS-c) with a mitochondrial structural stabiliser (SS-31). The two operate on orthogonal axes — signalling vs cristae architecture — so a mechanistic case for combination is straightforward in principle. No clinical data currently supports specific combination protocols and the pairing remains a research design topic.
3. Telomere + cellular repair: Epitalon + GHK-Cu
A pairing that combines a candidate telomere/pineal-axis intervention (Epitalon) with the most-studied connective-tissue and gene-expression repair signal (GHK-Cu). The combination is widely discussed in research-peptide literature but does not have a controlled-trial evidence base in this specific pairing.
4. Immunosenescence + telomere: Thymosin Alpha-1 + Epitalon
A pairing that brings together immune restoration and telomere-axis research. The mechanistic rationale is straightforward — immunosenescence and replicative senescence are both hallmarks of ageing — but the combination is not supported by published combination-trial data.
Important caveats
None of these stacks is a licensed therapeutic protocol in the UK. They appear in research and review literature as theoretical combinations and as research-context protocols. UK regulatory status of the individual peptides is summarised on each peptide page. None of these compounds is approved for human consumption by the MHRA.
For laboratory research, individual peptides are available from research-grade suppliers such as PeptideAuthority.co.uk and PeptideBarn.co.uk.